Boston, MA · Founded 2024 · Privately Held (backing)
Operator of an AI-based biotechnology company designed to accelerate drug discovery from hit identification to lead optimization. Boltz is based in Boston, MA and was founded in 2024. Its last reported valuation was $130 million in Jan 2026. It has raised $28 million.
Last reported valuation
$130.0M
Oct 2026
Priced at
—
Total raised
$28.0M
Last round
—
Team — not yet on record
No current team members for Boltz are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Boltz with a free account
·Watch Boltz: the Monday email on marks, rounds and moves
